- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BioLine RX Ltd (BLRX)BioLine RX Ltd stock price live, this page displays TASE BLRX stock exchange data. View the BLRX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the BioLine RX Ltd real time stock price chart below.
What Is the BioLine RX Ltd Stock Price Today?
The BioLine RX Ltd stock price today is 7.7.
What Is the Stock Symbol for BioLine RX Ltd?
The stock symbol for BioLine RX Ltd is "BLRX."
What Stock Exchange Does BioLine RX Ltd Trade On?
BioLine RX Ltd is listed and trades on the Tel Aviv stock exchange.
Is BioLine RX Ltd a Good Stock to Buy?
Determining whether BioLine RX Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BLRX quote. (ISIN: IL0011015182)
What Is the BioLine RX Ltd Stock Price Today?
The BioLine RX Ltd stock price today is 7.7.
What Is the Stock Symbol for BioLine RX Ltd?
The stock symbol for BioLine RX Ltd is "BLRX."
What Stock Exchange Does BioLine RX Ltd Trade On?
BioLine RX Ltd is listed and trades on the Tel Aviv stock exchange.
Is BioLine RX Ltd a Good Stock to Buy?
Determining whether BioLine RX Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BLRX quote. (ISIN: IL0011015182)
7.7
-0.2(-2.53%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.6
7.9
52 wk Range
7.2
44.0
BLRX Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.67.9
52 wk Range
7.244.0
Key Statistics
Edit
Fair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockBLRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
BioLine RX Ltd Company Profile
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company’s pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Compare BLRX to Peers and Sector
Metrics to compare | BLRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBLRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.3x | −1.9x | −0.6x | |
PEG Ratio | −0.02 | −0.20 | 0.00 | |
Price/Book | 3.0x | 2.5x | 2.6x | |
Price / LTM Sales | 1.2x | 15.8x | 3.2x | |
Upside (Analyst Target) | - | 197.2% | 44.6% | |
Fair Value Upside | Unlock | 5.7% | 7.3% | Unlock |
People Also Watch
FAQ
What Is the BioLine RX (BLRX) Stock Price Today?
The BioLine RX stock price today is 7.70
What Stock Exchange Does BioLine RX Trade On?
BioLine RX is listed and trades on the Tel Aviv stock exchange.
What Is the Stock Symbol for BioLine RX?
The stock symbol for BioLine RX is "BLRX."
What Is the BioLine RX Market Cap?
As of today, BioLine RX market cap is 92.39M.
What is BioLine RX Earnings Per Share?
The BioLine RX EPS is -0.017.
What Is the Next BioLine RX Earnings Date?
BioLine RX will release its next earnings report on 25 Mar 2025.
From a Technical Analysis Perspective, Is BLRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.